View Older Stories View More Recent Stories

Jun 9, 2021 04:30PM Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Jun 7, 2021 07:35AM Translate Bio (TBIO) Achieves Manufacturing Milestone Related to Influenza mRNA Vaccine Program
Jun 7, 2021 07:30AM Translate Bio Achieves Manufacturing Milestone Related to Influenza mRNA Vaccine Program
Jun 7, 2021 07:30AM Translate Bio Achieves Manufacturing Milestone Related to Influenza mRNA Vaccine Program
May 24, 2021 07:30AM Translate Bio to Participate in Upcoming Investor Conferences
May 18, 2021 10:00AM Translate Bio Presents Preclinical Results in Primary Ciliary Dyskinesia (PCD) at American Thoracic Society (ATS) 2021 International Conference
May 6, 2021 04:13PM Translate Bio Announces First Quarter 2021 Financial Results and Provides Corporate Update
May 6, 2021 04:13PM Translate Bio Announces First Quarter 2021 Financial Results and Provides Corporate Update
May 5, 2021 04:30PM Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Apr 28, 2021 07:30AM Translate Bio to Present at the 7th Annual Truist Securities Life Sciences Summit
Apr 20, 2021 04:30PM Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Apr 19, 2021 07:37AM Translate Bio (TBIO) announces Brendan Smith appointed as Chief Financial Officer
Apr 19, 2021 07:31AM Translate Bio (TBIO) Reports Publication of Preclinical Results of COVID-19 mRNA Vaccine Candidate MRT5500 in npj Vaccines
Apr 19, 2021 07:30AM Translate Bio Announces Key Leadership Additions and Promotions
Apr 19, 2021 07:30AM Translate Bio Announces Publication of Preclinical Results of COVID-19 mRNA Vaccine Candidate MRT5500 in npj Vaccines
Apr 19, 2021 07:30AM Translate Bio Announces Key Leadership Additions and Promotions
Apr 19, 2021 07:30AM Translate Bio Announces Publication of Preclinical Results of COVID-19 mRNA Vaccine Candidate MRT5500 in npj Vaccines
Apr 7, 2021 04:05PM Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Apr 7, 2021 04:05PM Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Mar 23, 2021 04:30PM Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Mar 23, 2021 04:30PM Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Mar 22, 2021 07:31AM Translate Bio (TBIO) Appoints Dr. Rand Sutherland as President
Mar 22, 2021 07:30AM Translate Bio Appoints Dr. Rand Sutherland as President
Mar 22, 2021 07:30AM Translate Bio Appoints Dr. Rand Sutherland as President
Mar 17, 2021 04:08PM Translate Bio (TBIO) Announces Results from Second Interim Data Analysis from Ongoing Phase 1/2 Clinical Trial of MRT5005 in Patients with Cystic Fibrosis
Mar 17, 2021 04:05PM Translate Bio Announces Results from Second Interim Data Analysis from Ongoing Phase 1/2 Clinical Trial of MRT5005 in Patients with Cystic Fibrosis (CF)
Mar 17, 2021 04:05PM Translate Bio Announces Results from Second Interim Data Analysis from Ongoing Phase 1/2 Clinical Trial of MRT5005 in Patients with Cystic Fibrosis (CF)
Sep 29, 2020 04:05PM Translate Bio to Participate in Upcoming Investor Conferences
Sep 8, 2020 07:36AM Translate Bio (TBIO) Resumes Enrollment and Dosing in Phase 1/2 Clinical Trial of MRT5005 in Cystic Fibrosis
Sep 8, 2020 07:30AM Translate Bio Resumes Enrollment and Dosing in Phase 1/2 Clinical Trial of MRT5005 in Cystic Fibrosis
Sep 8, 2020 07:30AM Translate Bio Resumes Enrollment and Dosing in Phase 1/2 Clinical Trial of MRT5005 in Cystic Fibrosis
Sep 3, 2020 07:30AM Translate Bio to Participate in Upcoming Investor Conferences
Aug 6, 2020 04:14PM Translate Bio Announces Second Quarter 2020 Financial Results and Reviews Recent Progress
Aug 6, 2020 04:14PM Translate Bio Announces Second Quarter 2020 Financial Results and Reviews Recent Progress
Jul 20, 2020 04:05PM Translate Bio Announces Closing of Expanded Collaboration and Licensing Agreement with Sanofi Pasteur to Develop mRNA Vaccines for All Infectious Diseases
Jul 20, 2020 04:05PM Translate Bio Announces Closing of Expanded Collaboration and Licensing Agreement with Sanofi Pasteur to Develop mRNA Vaccines for All Infectious Diseases
Jun 23, 2020 06:17AM Sanofi (SNY), Translate Bio (TBIO) Report Collaboration Expansion to Develop mRNA Vaccines Across All Infectious Disease Areas
Jun 23, 2020 12:59AM Sanofi and Translate Bio Expand Collaboration to Develop mRNA Vaccines Across All Infectious Disease Areas
Jun 23, 2020 12:59AM Sanofi and Translate Bio expand collaboration to develop mRNA vaccines across all infectious disease areas
Jun 23, 2020 12:59AM Sanofi and Translate Bio Expand Collaboration to Develop mRNA Vaccines Across All Infectious Disease Areas
May 28, 2020 07:30AM Translate Bio to Present at Jefferies Virtual Healthcare Conference
May 28, 2020 07:30AM Translate Bio to Present at Jefferies Virtual Healthcare Conference
May 12, 2020 04:05PM Translate Bio to Present at the Bank of America Securities Virtual 2020 Healthcare Conference
May 12, 2020 04:05PM Translate Bio to Present at the Bank of America Securities Virtual 2020 Healthcare Conference
May 7, 2020 04:26PM Translate Bio Announces First Quarter 2020 Financial Results and Provides Corporate Update
May 7, 2020 04:26PM Translate Bio Announces First Quarter 2020 Financial Results and Provides Corporate Update
Mar 27, 2020 05:53AM Translate Bio (TBIO), Sanofi Pasteur (SNY) Announce Collaboration to Develop a Novel mRNA Vaccine Candidate Against COVID-19
Mar 27, 2020 02:00AM Sanofi Pasteur and Translate Bio to Collaborate to Develop a Novel mRNA Vaccine Candidate Against COVID-19
Mar 27, 2020 02:00AM Sanofi and Translate Bio collaborate to develop novel mRNA vaccine candidate against COVID-19
Mar 27, 2020 02:00AM Sanofi Pasteur and Translate Bio to Collaborate to Develop a Novel mRNA Vaccine Candidate Against COVID-19
View More Recent Stories View Older Stories